期刊文献+

采用地西他滨联合CIG双预激治疗三例染色体核型异常的老年急性髓系白血病的临床观察并文献复习 被引量:3

下载PDF
导出
摘要 老年急性白血病(AML)的治疗是个难题。Johnson等汇总了多中心年龄≥60岁的2 255例老年AML采用常规化疗的疗效,平均完全缓解(CR)率46%,中位生存10.5个月,中位CR期是3个月,早期病死率30%[1]。传统化疗方案不仅缓解率低,而且药物相关毒性对患者生活质量和生存率造成严重影响,因此老年AML需要高效低毒的治疗方法。
出处 《中国药物与临床》 CAS 2016年第9期1308-1310,共3页 Chinese Remedies & Clinics
基金 山西省科技攻关项目(20140313011-16)
  • 相关文献

参考文献12

  • 1Oran B,Weisdorf DJ.Survival for olde rpatients with acute myeloid leukemia:apopulation-based study[J].Haematologica,2012,97(12):1916-1924.
  • 2钟济华,陈芳源,王海嵘,黄洪晖,钟华,韩洁英,宣正华,欧阳仁荣.CAG方案对急性髓系白血病细胞作用机制的研究[J].中华血液学杂志,2006,27(7):492-494. 被引量:25
  • 3尹惠子,单明,尤子龙,庞达.肿瘤发生过程中表观遗传学机制-DNA甲基化的研究进展[J].实用肿瘤学杂志,2015,29(2):173-177. 被引量:6
  • 4Lubbert M,Ruter BH,Claus R,et al.A multicenter phaseⅡtrail of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy[J].Haematologica,2012,97(3):393-401.
  • 5Richie EK,Feldman EJ,Chrietos PJ,et al.Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia[J].Leuk Lymphoma,2013,54(9):2003-2007.
  • 6Bhatnagar B,Duong VH,Gourdin TS,et al.Ten-day decitabine as inital therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy[J].Leuk Lymphoma,2014,55(7):1533-1537.
  • 7Ravandi F,Issa JP,Garcia-Manero G,et al.Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-rise myelodysplastic syndrome and chromosome 5and 7abnormalities[J].Cancer,2009,115(24):5746-5751.
  • 8Antonia Cagnetta,Sophia Adamia,Chirag Acharya,et al.Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics[J].Leukemia Res,2014,38(6):649-659.
  • 9Scandurn JM,Roboz GJ,Moh M,et al.PhaseⅠstudy of epigenetic priming with decitabine prior to standard induction chemotheapy for patients with AML[J].Blood,2011,118:1472-1480.
  • 10张秀群,邓银芬,张磊,戴丹,苏爱玲,张学忠,徐燕丽.地西他滨序贯半量CAG方案治疗中高危骨髓增生异常综合征及白血病转化四例[J].白血病.淋巴瘤,2012,21(7):433-435. 被引量:19

二级参考文献80

  • 1王俊英,魏丽华,王明琳.CAG方案在难治复发性急性髓系白血病中的应用[J].白血病.淋巴瘤,2004,13(6):361-362. 被引量:3
  • 2王春森,张晋林,王晓冬.去甲氧柔红霉素和阿糖胞苷治疗老年急性髓细胞性白血病疗效观察[J].实用老年医学,2006,20(1):68-68. 被引量:5
  • 3叶雪石,刘霆,崔旭,孟文彤,席亚明.骨髓增生异常综合征P15^(INK4B)基因甲基化及药物去甲基化作用[J].四川大学学报(医学版),2007,38(1):57-59. 被引量:9
  • 4Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature, 2004,429 (6990):457- 463.
  • 5Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat RevGenet,2002,3(6):415 -428.
  • 6Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. NEnglJ Med,2003,349(21) 2042-2054.
  • 7Estel[er M, ()uo M, Moreno V, et al. Hypermethylation- associated inactivation of the cellular retinol-binding-protein 1 gone in human cancer. Cancer Res,2002,62(20):5902 -5905.
  • 8Silverman LR, Demakos EP, Peterson BL, et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study o[ the cancer and leukemia group B. J Clin Oncol,2002,20(10) :2429- 2440.
  • 9Kantarjian H, Issa JP, Rosenfeld CS, et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase Ⅲ randomized study. Cancer,2006,106(8):1794 -1803.
  • 10Ravandi F, Kantarjian H, Giles F, et al. New agents in acute myeloid leukemia and other myeloid disorders. Cancer, 2004,100 (3):441 -454.

共引文献50

同被引文献35

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部